Chiropractors in Bandon, OR Accepting Medicare

4 Chiropractors found. Showing 1 - 4

Dr. Michael Brent Currie, D.C. BSN Chiropractor - Sports Physician Medicare: Not Enrolled in Medicare Practice Location: 55416 Melton Road, Bandon, OR 97411 Phone: 541-347-3408    Fax: 541-347-3408

Venus Crystal Smith, D.C Chiropractor Medicare: May Accept Medicare Assignments Practice Location: 780 2ndstreet Se Ste 6, Bandon, OR 97411 Phone: 541-347-5169

Sunshine Chiropractic Center, Pc. Chiropractor Medicare: Medicare Enrolled Practice Location: 780 2nd St Se Ste 6, Bandon, OR 97411 Phone: 541-347-5169

Bandon Chiropractic Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 55416 Melton Rd, Bandon, OR 97411 Phone: 541-347-3408

News Archive

Study finds increasing health care costs for patients with alcoholic cirrhosis

Health care costs for privately insured patients with alcoholic cirrhosis are nearly twice that of non‐alcoholic cirrhosis patients in the United States, according to research presented this week at The Liver Meeting - held by the American Association for the Study of Liver Diseases.

Takeda terminates development activities for fasiglifam (TAK-875)

Takeda Pharmaceutical Company Limited (Takeda) announced today that it has decided voluntarily to terminate the development activities for fasiglifam (TAK-875), an investigational treatment for type 2 diabetes, due to concerns about liver safety.

Meridian Bioscience seeks FDA marketing clearance for illumigene C. difficile molecular diagnostic test

Meridian Bioscience, Inc. announced today that it has submitted a 510(k) application to the United States Food and Drug Administration for marketing clearance of its new, simple molecular diagnostic test, illumigene™ C. difficile. illumigene is a simplified new technology platform, based upon loop amplification (LAMP) that makes molecular diagnostic testing possible for any size laboratory.

Mylan Pharmaceuticals launches Voriconazole for Oral Suspension

Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has launched Voriconazole for Oral Suspension, 40 mg/mL, which is the first generic version of Pfizer's VFEND for Oral Suspension.

Anaplastic large cell lymphoma: Defense mechanism against certain drugs promotes cancer growth

A general problem encountered in cancer therapy is that many patients develop resistance to a drug over the course of treatment.

Read more Medical News

› Verified 1 days ago